Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma

American Journal of Hematology

Volumn 73, Issue 3, 2003, Pages 143-148

  Boulanger, Emmanuelle ^a   Daniel, Marie Thérèse ^a   Agbalika, Félix ^a   Oksenhendler, Eric ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

AIDS associated lymphoma; Chemotherapy; KSHV HHV8; Methotrexate; Primary effusion lymphoma

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIDANOSINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LAMIVUDINE; METHOTREXATE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VINCRISTINE; ZIDOVUDINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG MEGADOSE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; IMMUNOPHENOTYPING; MALE; METHOTREXATE; MIDDLE AGED; PLEURAL EFFUSION; PROGNOSIS; RNA, VIRAL; SARCOMA, KAPOSI; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0037631606     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10341     Document Type: Article

References (22)

1. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
2. Ansari MQ, Dawson DB, Nado R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996;105:221-229.
3. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-1362.
4. Komanduri KV, Luce JA, McGrath MS, et al. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J AIDS Hum Retrovirol 1996;13:215-226.
5. Karcher DS, Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol 1997;28:801-808.
6. Valencia ME, Martinez P, Moreno V, et al. AIDS-related body cavity-based lymphomas, herpesvirus-8 and HIV infection: a study of seven cases. AIDS 1999;13:2603-2605.
7. Boulanger E, Agbalika F, Maarek O, et al. A clinical, molecular and cytogenetic study of twelve cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J 2001; 2:172-179.
8. Jacomet C, Girard PM, Lebrette MG, et al. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS 1997;11:1725-1730.
9. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132-136.
10. Gault E, Michel Y, Dehée A, et al. Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 2001;39:772-775.
11. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996;88:3124-3128.
12. Strauchen JA, Hauser AD, Burstein D, et al. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi's sarcoma. Ann Intern Med 1996;125:822-825.
13. Nakamura K, Katano H, Hoshino Y, et al. Human herpesvirus type 8 and Esptein-Barr virus-associated cutaneous lymphoma taking anaplastic large cell morphology in man with HIV infection. Br J Dermatol 1999;141:141-145.
14. Niitsu N, Chizuka A, Sasaki K, et al. Human herpes virus-8 associated with two cases of primary-effusion lymphoma. Ann Hematol 2000; 79:336-339.
15. Klepfish A, Sarid R, Shtalrid M, et al. Primary effusion lymphoma (PEL) in HIV-negative patients. A distinct clinical entity. Leuk Lymphoma 2001;41:439-443.
16. Pastore RD, Chadburn A, Kripas C, et al. Novel association of haemophagocytic syndrome with Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma. Br J Haematol 2000;111: 1112-1115.
17. Ascoli V, Signoretti S, Onetti-Muda A, et al. Primary effusion lymphoma in HIV-infected patients with multicentric Castleman's disease. J Pathol 2001;193:200-209.
18. Wan SH, Huffman DH, Azarnoff DL, et al. Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res 1974;34:3487-3491.
19. Evans WE, Pratt CB. Effect of pleural effusion on high-dose methotrexate kinetics. Clin Pharmacol Ther 1978;23:68-72.
20. Cinquina CC, Grogan E, Sun R, et al. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus. Virology 2000;268:201-217.
21. Jones D, Ballestas ME, Kaye KM, et al. Primary effusion lymphoma and Kaposi's sarcoma in a cardiac transplant recipient. N Engl J Med 1998;339:444-449.
22. Oksenhendler E, Clauvel JP, Jouveshomme S, et al. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol 1998;57:266.